Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 56 | ECE2018 | Next issue

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

Card image cap
ECE 2018, 19 - 22 May 2018; Barcelona, Spain

Poster Presentations: Thyroid

Endocrine tumours and neoplasia

ea0056p1009 | Endocrine tumours and neoplasia | ECE2018

Bethesda System for Reporting Thyroid Cytopathology (BSRTC): Category III and IV Frequency and Risk of Malignancyin the Era of Molecular Testing and after the Reclassification of Non Invasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features (NIFTPs)

Rosenblum Rachel Chava , Shtabsky Alexander , Marmor Silvia , Trejo Leonor , Yaish Iris , Yehuda Moshe , Barnes Sophie , Stern Naftali , Silman Zmira , Tordjman Karen

Background: The BSRTC aimed to standardize thyroid cytopathology reporting while enabling stratification of risk of malignancy (ROM) in thyroid nodules. Observational studies have demonstrated varying ROM for the Bethesda III and IV categories, further affected by the recent exemption of NIFTP. Finally, molecular testing is becoming a reasonable alternative for evaluating ROM in categories III and IV.Objective: To retrospectively establish the use of Bet...

ea0056p1010 | Endocrine tumours and neoplasia | ECE2018

Thresholds of basal and calcium stimulated calcitonin for diagnosis of medullary thyroid carcinoma

Baetu Mara , Gheorghiu Cristina , Corneci Cristina , Ioachim Dumitru , Caragheorgheopol Andra , Dobrescu Ruxandra , Badiu Corin

Introduction: The current revised medullary thyroid carcinoma (MTC) guidelines don’t specify reference ranges of basal (bCT) or stimulated serum calcitonin (sCT) levels for the diagnosis of MTC. These are important for early diagnosis and correct management.Objective: We aimed to set gender specific thresholds for bCT and sCT for MTC diagnosis.Patients and methods: CT samples during calcium-stimulation test (2...